This webcast examines the impact COVID-19 has had on supply chains and explores some of the challenges medical device manufacturers and supply chains could be facing.
Schedule 11:00 a.m. – 12:00 p.m. EST (4:00 p.m. – 5:00 p.m. BST)
Register now.
Prior to COVID-19 companies were already having to adjust to new or evolving geopolitical and cyber risks impacting their supply chain. While these risks were substantial, COVID-19 is forcing many companies—and even entire industries—to rethink and transform their global supply chain model. Some of these reasons include:
While COVID-19 may be the catalyst for companies to revisit their global supply chain strategy and accelerate the adoption of new models and capabilities, short-term actions need to be made to respond to the immediate challenge
Please join our experts in understanding how to approach some of the key risks currently being faced.
Speakers
The Kroll Investigations, Diligence and Compliance team partners with clients to anticipate, detect and manage regulatory and reputational risks associated with global ethics and compliance obligations.
Kroll is trusted by companies worldwide to help establish policies and programs aimed toward preventing fraud and complying with anti-money laundering (AML) and anti-bribery and corruption regulations.
Kroll helps clients navigate the complexities of today’s regulatory environment through a broad suite of anti-money laundering compliance screening and due diligence offers.